EP2213285

Use of sphingosine-1-phosphate (S1P) receptor agonists in combination with a second agent for the treatment of brain degenerative diseases

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    17.12.2004
  • :
    6.11.2013
  • :
    09177200.4
  • :
    16.12.2024
  • :
    Use of sphingosine-1-phosphate (S1P) receptor agonists in combination with a second agent for the treatment of brain degenerative diseases

17.12.2004
6.11.2013
  • :
    Novartis AG
  • :
    Lichtstrasse 35, 4056, Basel, CH
  • :
    Brinkmann, Volker
  • :
    Freiburg, DE
  • :
    Kaneider, Nicole
  • :
    Innsbruck, AT
  • :
    Wiedermann, Christian J.
  • :
    Innsbruck, AT
  • :
    0329498
  • :
    19.12.2003
  • :
    GB
  • :
    A61K 31/133, A61K 31/135, A61K 31/00, A61K 45/06, A61K 31/661, A61P 25/28